Assessing the metabolic impact of aripiprazole versus risperidone in the treatment of schizophrenia: a randomized double-blind controlled clinical trial. [PDF]
BMC PsychiatryRahimi Darehbagh R +2 more
europepmc +1 more source
Aripiprazole for treatment of attenuated psychosis syndrome in an adolescent with 22q11.21 deletion syndrome: A case report. [PDF]
Medicine (Baltimore)Algarzae NK +6 more
europepmc +1 more source
A Multicentre, 4-Year Mirror-Image Study Comparing the Effectiveness of Long-Acting Injectable Antipsychotics in the Treatment of Bipolar Disorder: Results From the LAICO Study. [PDF]
Bipolar DisordGarcía-Carmona JA +5 more
europepmc +1 more source
Managing Bipolar Disorder With Aripiprazole Once Monthly: From Symptom Stabilization to Functional Recovery. [PDF]
Psychiatry InvestigYang HR +6 more
europepmc +1 more source
Combining Three Long-acting Injectable Antipsychotics: A Case Series. [PDF]
Clin Psychopharmacol Neurosciİnci Kenar AN, Balki Tekin S.
europepmc +1 more source
Association of Atypical Antipsychotics With Lipid Abnormalities in Adult Patients With Schizophrenia: A Scoping Review. [PDF]
Neuropsychopharmacol RepAbavana V, Sadiq S.
europepmc +1 more source
Partial agonist antipsychotic drugs differentially interact with a secondary binding site at the dopamine D2 receptor. [PDF]
Int J NeuropsychopharmacolÅgren R, Sahlholm K.
europepmc +1 more source
Transient Mood Elevation Without a Manic Switch: Goldenseal-Augmented Oral Glutamatergic Regimen in Bipolar Depression With Comorbid Obsessive-Compulsive Disorder (OCD). [PDF]
CureusCheung N.
europepmc +1 more source
Gender transition and intellectual developmental disorders: a case report. [PDF]
Sex MedSoldati L +3 more
europepmc +1 more source
The effect of early initiation of aripiprazole once-monthly 400 mg on health care resource utilization and health care costs in patients diagnosed with bipolar I disorder: Real-world evidence from US claims data. [PDF]
J Manag Care Spec PharmAwasthi S +3 more
europepmc +1 more source